{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:12:51Z","timestamp":1788469971286,"version":"build-2803163510"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s11033-020-05869-7","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T20:02:37Z","timestamp":1602100957000},"page":"8179-8187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Liquid biopsy approaches for pleural effusion in lung cancer patients"],"prefix":"10.1007","volume":"47","author":[{"given":"Gayathri","family":"Baburaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama Rao","family":"Damerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik S","family":"Udupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetiparna","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Munisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Kolesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3322-5399","authenticated-orcid":false,"given":"Mahadev","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"5","key":"5869_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"10100","key":"5869_CR2","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390(10100):1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2","journal-title":"Lancet"},{"issue":"9","key":"5869_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA (2014) Annual Report to the Nation on the status of cancer, 1975\u20132010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9):1290\u20131314. https:\/\/doi.org\/10.1002\/cncr.28509","journal-title":"Cancer"},{"issue":"1","key":"5869_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A (2018) Cancer statistics. Ca Cancer J Clin 68(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21442","journal-title":"Ca Cancer J Clin"},{"issue":"1","key":"5869_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/ajrccm.153.1.8542152","volume":"153","author":"D Sazon","year":"1996","unstructured":"Sazon D, Santiago SM, Soo Hoo G, Khonsary A, Brown C, Mandelkern M, Blahd W, Williams AJ (1996) Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 153(1):417\u2013421. https:\/\/doi.org\/10.1164\/ajrccm.153.1.8542152","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"5869_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/caac.21172","volume":"63","author":"R Wender","year":"2013","unstructured":"Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Scott Gazelle G, Kelsey DK (2013) American cancer society lung cancer screening guidelines. CA Cancer J Clin 63(2):106\u201317. https:\/\/doi.org\/10.3322\/caac.21172","journal-title":"CA Cancer J Clin"},{"issue":"5\u20136","key":"5869_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1615\/CritRevOncog.v20.i5-6.90","volume":"20","author":"JH Tang","year":"2015","unstructured":"Tang JH, Chia D (2015) Liquid biopsies in the screening of oncogenic mutations in NSCLC and its application in targeted therapy. Crit Rev Oncog 20(5\u20136):351\u201371. https:\/\/doi.org\/10.1615\/CritRevOncog.v20.i5-6.90","journal-title":"Crit Rev Oncog"},{"issue":"3","key":"5869_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/mi9030100","volume":"9","author":"M Lim","year":"2018","unstructured":"Lim M, Kim C-J, Sunkara V, Kim M-H, Cho Y-K (2018) Liquid biopsy in lung cancer: clinical applications of circulating biomarkers (CTCs and ctDNA). Micromachines (Basel) 9(3):100. https:\/\/doi.org\/10.3390\/mi9030100","journal-title":"Micromachines (Basel)"},{"issue":"3","key":"5869_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/jcm8030373","volume":"8","author":"RA Mathai","year":"2019","unstructured":"Mathai RA, Vidya RVS, Reddy BS, Thomas L, Udupa K, Kolesar J, Rao M (2019) Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology. J Clin Med 8(3):373. https:\/\/doi.org\/10.3390\/jcm8030373","journal-title":"J Clin Med"},{"key":"5869_CR10","doi-asserted-by":"publisher","unstructured":"Dom\u00ednguez-Vigil IG, Moreno-Mart\u00ednez AK, Wang JY, Roehrl MH, Barrera-Salda\u00f1a HA (2018) The dawn of the liquid biopsy in the fight against cancer. Oncotarget 9(2):2912\u20132922. https:\/\/doi.org\/https:\/\/doi.org\/10.18632\/oncotarget.23131","DOI":"10.18632\/oncotarget.23131"},{"issue":"7","key":"5869_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/jcm8070998","volume":"8","author":"L Pasini","year":"2019","unstructured":"Pasini L, Ulivi P (2019) Liquid biopsy for the detection of resistance mechanisms in NSCLC: comparison of different blood biomarkers. J Clin Med 8(7):998. https:\/\/doi.org\/10.3390\/jcm8070998","journal-title":"J Clin Med"},{"issue":"5","key":"5869_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","unstructured":"Alix-Panabi\u00e8res C, Pantel K (2016) Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Cancer Discov 6(5):479\u2013491. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1483","journal-title":"Cancer Discov"},{"issue":"9","key":"5869_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G, Marsoni S, Siena S, Bardelli A (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 14(9):531\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2017.14","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"5869_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/1759-7714.13006","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Xie Z, Shi H, Du W, Peng L, Han W, Duan F, Zhang X, Chen M, Duan J (2019) Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling. Thorac Cancer 10(4):823\u2013831. https:\/\/doi.org\/10.1111\/1759-7714.13006","journal-title":"Thorac Cancer"},{"issue":"2","key":"5869_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/jclinpath-2012-201194","volume":"66","author":"G Ellison","year":"2013","unstructured":"Ellison G, Zhu G, Moulis A, Dearden S, Speake G, McCormack R (2013) EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 66(2):79\u201389. https:\/\/doi.org\/10.1136\/jclinpath-2012-201194","journal-title":"J Clin Pathol"},{"key":"5869_CR16","doi-asserted-by":"publisher","first-page":"175883591879463","DOI":"10.1177\/1758835918794630","volume":"10","author":"R Palmirotta","year":"2018","unstructured":"Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pell\u00e8 E, Quaresmini D, Tucci M, Silvestris F (2018) Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 10:1758835918794630. https:\/\/doi.org\/10.1177\/1758835918794630","journal-title":"Ther Adv Med Oncol"},{"issue":"3","key":"5869_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.lungcan.2005.02.016","volume":"49","author":"M-J Huang","year":"2005","unstructured":"Huang M-J, Lim K-H, Tzen C-Y, Hsu H-S, Yen Y, Huang B-S (2005) EGFR mutations in malignant pleural effusion of non-small cell lung cancer: a case report. Lung Cancer 49(3):413\u2013415. https:\/\/doi.org\/10.1016\/j.lungcan.2005.02.016","journal-title":"Lung Cancer"},{"key":"5869_CR18","doi-asserted-by":"publisher","first-page":"15009","DOI":"10.1038\/nrdp.2015.9","volume":"1","author":"C Gridelli","year":"2015","unstructured":"Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R (2015) Non-small-cell lung cancer. Nat Rev Dis Primers 1:15009. https:\/\/doi.org\/10.1038\/nrdp.2015.9","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"5869_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fon.15.311","volume":"12","author":"P Brown","year":"2016","unstructured":"Brown P (2016) The cobas\u00ae EGFR mutation test v2 assay. Future Oncol 12(4):451\u20132. https:\/\/doi.org\/10.2217\/fon.15.311","journal-title":"Future Oncol"},{"key":"5869_CR20","doi-asserted-by":"publisher","unstructured":"Keshishyan S, Harris K (2017) Asymptomatic malignant pleural effusion to observe or to manage. J Thorac Dis 9(Suppl 10):S1146-S1147. https:\/\/doi.org\/https:\/\/doi.org\/10.21037\/jtd.2017.06.52","DOI":"10.21037\/jtd.2017.06.52"},{"issue":"4","key":"5869_CR21","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1183\/09031936.00167407","volume":"32","author":"S Wu","year":"2008","unstructured":"Wu S, Gow C-H, Yu C, Chang Y, Yang C-H, Hsu Y, Shih J, Lee Y, Yang P (2008) Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J 32(4):924\u201330. https:\/\/doi.org\/10.1183\/09031936.00167407","journal-title":"Eur Respir J"},{"issue":"10","key":"5869_CR22","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","volume":"7","author":"D Morgensztern","year":"2012","unstructured":"Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R (2012) Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non\u2013small-cell lung cancer. J Thorac Oncol 7(10):1485\u20139. https:\/\/doi.org\/10.1097\/JTO.0b013e318267223a","journal-title":"J Thorac Oncol"},{"issue":"2","key":"5869_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.lungcan.2013.04.023","volume":"81","author":"CD Yeo","year":"2013","unstructured":"Yeo CD, Kim JW, Kim KH, Ha JH, Rhee CK, Kim SJ, Kim YK, Park CK, Lee SH, Park MS (2013) Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing. Lung Cancer 81(2):207\u2013212. https:\/\/doi.org\/10.1016\/j.lungcan.2013.04.023","journal-title":"Lung Cancer"},{"issue":"2","key":"5869_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1076-6332(05)80373-3","volume":"3","author":"CC Blackmore","year":"1996","unstructured":"Blackmore CC, Black WC, Dallas RV, Crow HC (1996) Pleural fluid volume estimation: a chest radiograph prediction rule. Acad Radiol 3(2):103\u20139. https:\/\/doi.org\/10.1016\/S1076-6332(05)80373-3","journal-title":"Acad Radiol"},{"issue":"2","key":"5869_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jcu.10141","volume":"31","author":"I Kocijan\u010di\u010d","year":"2003","unstructured":"Kocijan\u010di\u010d I, Vidmar K, Ivanovi-Herceg Z (2003) Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound 31(2):69\u201374. https:\/\/doi.org\/10.1002\/jcu.10141","journal-title":"J Clin Ultrasound"},{"issue":"2","key":"5869_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccm.2006.02.001","volume":"27","author":"NR Qureshi","year":"2006","unstructured":"Qureshi NR, Gleeson FV (2006) Imaging of pleural disease. Clin Chest Med 27(2):193\u2013213. https:\/\/doi.org\/10.1016\/j.ccm.2006.02.001","journal-title":"Clin Chest Med"},{"issue":"3","key":"5869_CR27","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1378\/chest.118.3.604","volume":"118","author":"J Hierholzer","year":"2000","unstructured":"Hierholzer J, Luo L, Bittner RC, Stroszczynski C, Schoenfeld N, Dorow P, Loddenkemper R, Grassot A (2000) MRI and CT in the differential diagnosis of pleural disease. Chest 118(3):604\u2013609. https:\/\/doi.org\/10.1378\/chest.118.3.604","journal-title":"Chest"},{"key":"5869_CR28","doi-asserted-by":"publisher","DOI":"10.4065\/83.2.235","author":"JE Heffner","year":"2008","unstructured":"Heffner JE, Klein JS (2008) Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc. https:\/\/doi.org\/10.4065\/83.2.235","journal-title":"Mayo Clin Proc"},{"key":"5869_CR29","doi-asserted-by":"publisher","unstructured":"Ili\u00e9 M, Hofman P (2016) Pros: can tissue biopsy be replaced by liquid biopsy? Transl Lung Cancer Res 5(4):420. https:\/\/doi.org\/https:\/\/doi.org\/10.21037\/tlcr.2016.08.06","DOI":"10.21037\/tlcr.2016.08.06"},{"key":"5869_CR30","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.2147\/OTT.S203070","volume":"12","author":"Z Wu","year":"2019","unstructured":"Wu Z, Yang Z, Dai Y, Zhu Q, Chen L-A (2019) Update on liquid biopsy in clinical management of non-small cell lung cancer. Onco Targets Ther 12:5097\u20139. https:\/\/doi.org\/10.2147\/OTT.S203070","journal-title":"Onco Targets Ther"},{"issue":"12","key":"5869_CR31","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1515\/cclm-2016-0851","volume":"55","author":"S Shin","year":"2017","unstructured":"Shin S, Kim J, Kim Y, Cho S-M, Lee K-A (2017) Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients. Clin Chem Lab Med 55(12):1962\u20139. https:\/\/doi.org\/10.1515\/cclm-2016-0851","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"5869_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/jclinpath-2013-201728","volume":"66","author":"X Liu","year":"2013","unstructured":"Liu X, Lu Y, Zhu G, Lei Y, Zheng L, Qin H, Tang C, Ellison G, McCormack R, Ji Q (2013) The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies. J Clin Pathol 66(12):1065\u20139. https:\/\/doi.org\/10.1136\/jclinpath-2013-201728","journal-title":"J Clin Pathol"},{"issue":"7","key":"5869_CR33","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1097\/JTO.0000000000000203","volume":"9","author":"H Akamatsu","year":"2014","unstructured":"Akamatsu H, Koh Y, Kenmotsu H, Naito T, Serizawa M, Kimura M, Mori K, Imai H, Ono A, Shukuya T (2014) Multiplexed molecular profiling of lung cancer using pleural effusion. J Thorac Oncol 9(7):1048\u201352. https:\/\/doi.org\/10.1097\/JTO.0000000000000203","journal-title":"J Thorac Oncol"},{"issue":"2","key":"5869_CR34","doi-asserted-by":"publisher","first-page":"e89946","DOI":"10.1371\/journal.pone.0089946","volume":"9","author":"D Liu","year":"2014","unstructured":"Liu D, Lu Y, Hu Z, Wu N, Nie X, Xia Y, Han Y, Li Q, Zhu G, Bai C (2014) Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma. PloS One 9(2):e89946. https:\/\/doi.org\/10.1371\/journal.pone.0089946","journal-title":"PloS One"},{"issue":"3","key":"5869_CR35","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1078-0432.CCR-12-1958","volume":"19","author":"F Buttitta","year":"2013","unstructured":"Buttitta F, Felicioni L, Del Grammastro M, Filice G, Di Lorito A, Malatesta S, Viola P, Centi I, D'Antuono T, Zappacosta R (2013) Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. Clin Cancer Res 19(3):691\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1958","journal-title":"Clin Cancer Res"},{"issue":"7","key":"5869_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1513\/AnnalsATS.201609-709OC","volume":"14","author":"J Carter","year":"2017","unstructured":"Carter J, Miller JA, Feller-Kopman D, Ettinger D, Sidransky D, Maleki Z (2017) Molecular profiling of malignant pleural effusion in metastatic non\u2013small-cell lung carcinoma. The effect of preanalytical factors. Ann Am Thorac Soc 14(7):1169\u20131176. https:\/\/doi.org\/10.1513\/AnnalsATS.201609-709OC","journal-title":"Ann Am Thorac Soc"},{"key":"5869_CR37","doi-asserted-by":"publisher","unstructured":"Liu L, Shao D, Deng Q, Tang H, Wang J, Liu J, Guo F, Lin Y, Peng Z, Mao M (2018) Next generation sequencing-based molecular profiling of lung adenocarcinoma using pleural effusion specimens. J Thorac Dis 10(5):2631\u20132637. https:\/\/doi.org\/https:\/\/doi.org\/10.21037\/jtd.2018.04.125","DOI":"10.21037\/jtd.2018.04.125"},{"issue":"2","key":"5869_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jmoldx.2017.10.007","volume":"20","author":"S-R Yang","year":"2018","unstructured":"Yang S-R, Lin C-Y, Stehr H, Long SR, Kong CS, Berry GJ, Zehnder JL, Kunder CA (2018) Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma. J Mol Diagn 20(2):184\u201394. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.10.007","journal-title":"J Mol Diagn"},{"issue":"10","key":"5869_CR39","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/sj.bjc.6603428","volume":"95","author":"H Kimura","year":"2006","unstructured":"Kimura H, Fujiwara Y, Sone T, Kunitoh H, Tamura T, Kasahara K, Nishio K (2006) EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer 95(10):1390\u201395. https:\/\/doi.org\/10.1038\/sj.bjc.6603428","journal-title":"Br J Cancer"},{"issue":"6","key":"5869_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","volume":"32","author":"LA Diaz Jr","year":"2014","unstructured":"Diaz LA Jr, Bardelli A (2014) Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32(6):579\u201386. https:\/\/doi.org\/10.1200\/JCO.2012.45.2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"5869_CR41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1749-6632.2000.tb06608.x","volume":"906","author":"M Stroun","year":"2000","unstructured":"Stroun M, Maurice P, Vasioukhin V, Lyautey J, Lederrey C, Lefort F, Rossier A, Chen XQ, Anker P (2000) The origin and mechanism of circulating DNA. Ann N Y Acad Sci 906(1):161\u20138. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06608.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"5869_CR42","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11(6):426\u201337. https:\/\/doi.org\/10.1038\/nrc3066","journal-title":"Nat Rev Cancer"},{"key":"5869_CR43","doi-asserted-by":"publisher","unstructured":"Cheng F, Su L, Qian C (2016) Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget 7(30):48832-48841. https:\/\/doi.org\/https:\/\/doi.org\/10.18632\/oncotarget.9453","DOI":"10.18632\/oncotarget.9453"},{"issue":"8","key":"5869_CR44","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/1878-0261.12077","volume":"11","author":"J Li","year":"2017","unstructured":"Li J, Dittmar RL, Xia S, Zhang H, Du M, Huang CC, Druliner BR, Boardman L, Wang L (2017) Cell-free DNA copy number variations in plasma from colorectal cancer patients. Mol Oncol 11(8):1099\u2013111. https:\/\/doi.org\/10.1002\/1878-0261.12077","journal-title":"Mol Oncol"},{"issue":"34","key":"5869_CR45","doi-asserted-by":"publisher","first-page":"56398","DOI":"10.18632\/oncotarget.17657","volume":"8","author":"A Soave","year":"2017","unstructured":"Soave A, Chun FK-H, Hillebrand T, Rink M, Weisbach L, Steinbach B, Fisch M, Pantel K, Schwarzenbach H (2017) Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. Oncotarget 8(34):56398\u201356407. https:\/\/doi.org\/10.18632\/oncotarget.17657","journal-title":"Oncotarget"},{"issue":"5","key":"5869_CR46","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/1535-7163.MCT-16-0436","volume":"16","author":"H Husain","year":"2017","unstructured":"Husain H, Nykin D, Bui N, Quan D, Gomez G, Woodward B, Venkatapathy S, Duttagupta R, Fung E, Lippman SM (2017) Cell-free DNA from ascites and pleural effusions: molecular insights into genomic aberrations and disease biology. Mol Cancer Ther 16(5):948\u201355. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0436","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"5869_CR47","doi-asserted-by":"publisher","first-page":"13111","DOI":"10.1007\/s13277-016-5190-z","volume":"37","author":"Z Li","year":"2016","unstructured":"Li Z, Guo X, Tang L, Peng L, Chen M, Luo X, Wang S, Xiao Z, Deng Z, Dai L (2016) Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing. Tumour Biol 37(10):13111\u20139. https:\/\/doi.org\/10.1007\/s13277-016-5190-z","journal-title":"Tumour Biol"},{"issue":"10","key":"5869_CR48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/cncy.21583","volume":"123","author":"A Kawahara","year":"2015","unstructured":"Kawahara A, Fukumitsu C, Taira T, Abe H, Takase Y, Murata K, Yamaguchi T, Azuma K, Ishii H, Takamori S (2015) Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings. Cancer Cytopathol 123(10):620\u20138. https:\/\/doi.org\/10.1002\/cncy.21583","journal-title":"Cancer Cytopathol"},{"issue":"D1","key":"5869_CR49","doi-asserted-by":"publisher","first-page":"D516","DOI":"10.1093\/nar\/gky1029","volume":"47","author":"M Pathan","year":"2019","unstructured":"Pathan M, Fonseka P, Chitti SV, Kang T, Sanwlani R, Van Deun J, Hendrix A, Mathivanan S (2019) Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res 47(D1):D516\u2013D9. https:\/\/doi.org\/10.1093\/nar\/gky1029","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"5869_CR50","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1186\/s12885-018-5138-3","volume":"18","author":"JS Lee","year":"2018","unstructured":"Lee JS, Hur JY, Kim IA, Kim HJ, Choi CM, Lee JC, Kim WS, Lee KY (2018) Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA. BMC cancer 18(1):1236. https:\/\/doi.org\/10.1186\/s12885-018-5138-3","journal-title":"BMC cancer"},{"issue":"6","key":"5869_CR51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/cr.2014.44","volume":"24","author":"BK Thakur","year":"2014","unstructured":"Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24(6):766\u20139. https:\/\/doi.org\/10.1038\/cr.2014.44","journal-title":"Cell Res"},{"issue":"6","key":"5869_CR52","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.drudis.2017.03.004","volume":"22","author":"I Vanni","year":"2017","unstructured":"Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S (2017) Exosomes: a new horizon in lung cancer. Drug Discov Today 22(6):927\u201336. https:\/\/doi.org\/10.1016\/j.drudis.2017.03.004","journal-title":"Drug Discov Today"},{"issue":"7","key":"5869_CR53","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1074\/jbc.C113.532267","volume":"289","author":"C Kahlert","year":"2014","unstructured":"Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, Zhang J, Weitz J, Chin L, Futreal A (2014) Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289(7):3869\u201375. https:\/\/doi.org\/10.1074\/jbc.C113.532267","journal-title":"J Biol Chem"},{"issue":"14","key":"5869_CR54","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/pmic.201200323","volume":"13","author":"JO Park","year":"2013","unstructured":"Park JO, Choi DY, Choi DS, Kim HJ, Kang JW, Jung JH, Lee JH, Kim J, Freeman MR, Lee KY (2013) Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 13(14):2125\u20132134. https:\/\/doi.org\/10.1002\/pmic.201200323","journal-title":"Proteomics"},{"issue":"12","key":"5869_CR55","doi-asserted-by":"publisher","first-page":"15835","DOI":"10.1007\/s13277-016-5410-6","volume":"37","author":"J Lin","year":"2016","unstructured":"Lin J, Wang Y, Zou Y-Q, Chen X, Huang B, Liu J, Xu Y-M, Li J, Zhang J, Yang W-M (2016) Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia. Tumor Biol 37(12):15835\u201345. https:\/\/doi.org\/10.1007\/s13277-016-5410-6","journal-title":"Tumor Biol"},{"issue":"11","key":"5869_CR56","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling H, Fabbri M, Calin GA (2013) MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12(11):847\u201365. https:\/\/doi.org\/10.1038\/nrd4140","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"5869_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5114\/wo.2019.89241","volume":"23","author":"W Wojczakowski","year":"2019","unstructured":"Wojczakowski W, Kobylarek D, Lindner J, Limphaibool N, Kaczmarek M (2019) MicroRNAs\u2013novel biomarkers for malignant pleural effusions. Contemp Oncol 23(3):133\u2013140. https:\/\/doi.org\/10.5114\/wo.2019.89241","journal-title":"Contemp Oncol"},{"issue":"21","key":"5869_CR58","doi-asserted-by":"publisher","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","volume":"65","author":"Y Hayashita","year":"2005","unstructured":"Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T (2005) A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21):9628\u201332. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-2352","journal-title":"Cancer Res"},{"issue":"9","key":"5869_CR59","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101(9):2999\u20133004. https:\/\/doi.org\/10.1073\/pnas.0307323101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"5869_CR60","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99(24):15524\u20139. https:\/\/doi.org\/10.1073\/pnas.242606799","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"5869_CR61","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1177\/1947601910396213","volume":"1","author":"BN Davis-Dusenbery","year":"2010","unstructured":"Davis-Dusenbery BN, Hata A (2010) MicroRNA in cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 1(11):1100\u201314. https:\/\/doi.org\/10.1177\/1947601910396213","journal-title":"Genes Cancer"},{"issue":"1\u20132","key":"5869_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.03.004","volume":"717","author":"A Etheridge","year":"2011","unstructured":"Etheridge A, Lee I, Hood L, Galas D, Wang K (2011) Extracellular microRNA: a new source of biomarkers. Mutat Res 717(1\u20132):85\u201390. https:\/\/doi.org\/10.1016\/j.mrfmmm.2011.03.004","journal-title":"Mutat Res"},{"issue":"1","key":"5869_CR63","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","volume":"112","author":"KE Resnick","year":"2009","unstructured":"Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112(1):55\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2008.08.036","journal-title":"Gynecol Oncol"},{"issue":"44","key":"5869_CR64","doi-asserted-by":"publisher","first-page":"e8361","DOI":"10.1097\/MD.0000000000008361","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xu Y-M, Zou Y-Q, Lin J, Huang B, Liu J, Li J, Zhang J, Yang W-M, Min Q-H (2017) Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions. Medicine 96(44):e8361. https:\/\/doi.org\/10.1097\/MD.0000000000008361","journal-title":"Medicine"},{"issue":"11","key":"5869_CR65","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64(11):3753\u20136. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0637","journal-title":"Cancer Res"},{"issue":"5","key":"5869_CR66","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.3892\/etm.2018.6732","volume":"16","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu S (2018) Role of miR-520b in non-small cell lung cancer. Exp Ther Med 16(5):3987\u201395. https:\/\/doi.org\/10.3892\/etm.2018.6732","journal-title":"Exp Ther Med"},{"issue":"8","key":"5869_CR67","doi-asserted-by":"publisher","first-page":"e43268","DOI":"10.1371\/journal.pone.0043268","volume":"7","author":"T Wang","year":"2012","unstructured":"Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y, Liu B, Yu L, Hou Y (2012) Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PloS One 7(8):e43268. https:\/\/doi.org\/10.1371\/journal.pone.0043268","journal-title":"PloS One"},{"issue":"4","key":"5869_CR68","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3892\/ol.2014.2404","volume":"8","author":"HS Han","year":"2014","unstructured":"Han HS, Jo YN, Lee JY, Choi SY, Jeong Y, Yun J, Lee OJ (2014) Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion. Oncol Lett 8(4):1889\u201395. https:\/\/doi.org\/10.3892\/ol.2014.2404","journal-title":"Oncol Lett"},{"issue":"3","key":"5869_CR69","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9(3):189\u201398. https:\/\/doi.org\/10.1016\/j.ccr.2006.01.025","journal-title":"Cancer Cell"},{"issue":"1","key":"5869_CR70","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","volume":"10","author":"G Rabinowits","year":"2009","unstructured":"Rabinowits G, Ger\u00e7el-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10(1):42\u20136. https:\/\/doi.org\/10.3816\/CLC.2009.n.006","journal-title":"Clin Lung Cancer"},{"key":"5869_CR71","doi-asserted-by":"publisher","first-page":"635748","DOI":"10.1155\/2015\/635748","volume":"2015","author":"G Ak","year":"2015","unstructured":"Ak G, Tomaszek SC, Kosari F, Metintas M, Jett JR, Metintas S, Yildirim H, Dundar E, Dong J, Aubry MC (2015) MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion. Biomed Res Int 2015:635748. https:\/\/doi.org\/10.1155\/2015\/635748","journal-title":"Biomed Res Int"},{"key":"5869_CR72","doi-asserted-by":"publisher","unstructured":"Tamiya H, Mitani A, Saito A, Ishimori T, Saito M, Isago H, Jo T, Yamauchi Y, Tanaka G, Nagase T (2018) Exosomal MicroRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion. Anticancer Res 38(12):6707-6714. https:\/\/doi.org\/10.21873\/anticanres.13039.","DOI":"10.21873\/anticanres.13039"},{"issue":"19","key":"5869_CR73","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1097\/MD.0000000000008361","volume":"9","author":"L Tong","year":"2019","unstructured":"Tong L, Ding N, Tong X, Li J, Zhang Y, Wang X, Xu X, Ye M, Li C, Wu X (2019) Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer. Theranostics 9(19):5532\u201341. https:\/\/doi.org\/10.1097\/MD.0000000000008361","journal-title":"Theranostics"},{"issue":"2","key":"5869_CR74","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.canlet.2016.02.002","volume":"374","author":"A Szpechcinski","year":"2016","unstructured":"Szpechcinski A, Rudzinski P, Kupis W, Langfort R, Orlowski T, Chorostowska-Wynimko J (2016) Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules. Cancer Lett 374(2):202\u20137. https:\/\/doi.org\/10.1016\/j.canlet.2016.02.002","journal-title":"Cancer Lett"},{"issue":"1","key":"5869_CR75","doi-asserted-by":"publisher","first-page":"00016","DOI":"10.1183\/23120541.00016-2019","volume":"5","author":"K Hummelink","year":"2019","unstructured":"Hummelink K, Muller M, Linders TC, van der Noort V, Nederlof PM, Baas P, Burgers S, Smit EF, Meijer GA, van den Heuvel MM (2019) Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions. ERJ Open Res 5(1):00016\u20132019. https:\/\/doi.org\/10.1183\/23120541.00016-2019","journal-title":"ERJ Open Res"},{"issue":"12","key":"5869_CR76","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/1878-0261.12574","volume":"13","author":"S Villatoro","year":"2019","unstructured":"Villatoro S, Mayo-de-las-Casas C, Jordana-Ariza N, Viteri-Ram\u00edrez S, Garz\u00f3n-Iba\u00f1ez M, Moya-Horno I, Garc\u00eda-Pel\u00e1ez B, Gonz\u00e1lez-Cao M, Malapelle U, Balada-Bel A (2019) Prospective detection of mutations in cerebrospinal fluid, pleural effusion and ascites of advanced cancer patients to guide treatment decisions. Mol Oncol 13(12):2633\u20132645. https:\/\/doi.org\/10.1002\/1878-0261.12574","journal-title":"Mol Oncol"},{"issue":"4","key":"5869_CR77","doi-asserted-by":"publisher","first-page":"392","DOI":"10.21037\/tlcr.2019.08.14","volume":"8","author":"Z Song","year":"2019","unstructured":"Song Z, Cai Z, Yan J, Shao YW, Zhang Y (2019) Liquid biopsies using pleural effusion-derived exosomal DNA in advanced lung adenocarcinoma. Transl Lung Cancer Res 8(4):392\u2013400. https:\/\/doi.org\/10.21037\/tlcr.2019.08.14","journal-title":"Transl Lung Cancer Res"},{"issue":"6378","key":"5869_CR78","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.aar3247","volume":"359","author":"JD Cohen","year":"2018","unstructured":"Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 359(6378):926\u2013930. https:\/\/doi.org\/10.1126\/science.aar3247","journal-title":"Science"},{"issue":"15","key":"5869_CR79","doi-asserted-by":"publisher","first-page":"353","DOI":"10.21037\/atm.2019.06.33","volume":"7","author":"SF Awadallah","year":"2019","unstructured":"Awadallah SF, Bowling MR, Sharma N, Mohan A (2019) Malignant pleural effusion and cancer of unknown primary site: a review of literature. Ann Transl Med 7(15):353. https:\/\/doi.org\/10.21037\/atm.2019.06.33","journal-title":"Ann Transl Med"},{"issue":"2","key":"5869_CR80","first-page":"157","volume":"16","author":"R Darooei","year":"2017","unstructured":"Darooei R, Sanadgol G, Gh-Nataj A, Almasnia M, Darivishi A, Eslaminejad A, Raoufy MR (2017) Discriminating tuberculous pleural effusion from malignant pleural effusion based on routine pleural fluid biomarkers, using mathematical methods. Tanaffos 16(2):157\u2013165","journal-title":"Tanaffos"},{"key":"5869_CR81","doi-asserted-by":"publisher","unstructured":"Johnston WW (1985) The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56(4):905-909. https:\/\/doi.org\/https:\/\/doi.org\/10.1002\/1097-0142(19850815)56:4<905::aid-cncr2820560435>3.0.co;2-u","DOI":"10.1002\/1097-0142(19850815)56:4<905::aid-cncr2820560435>3.0.co;2-u"},{"issue":"9","key":"5869_CR82","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9):985\u2013990. https:\/\/doi.org\/10.1038\/nm.1789","journal-title":"Nat Med"},{"issue":"1","key":"5869_CR83","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12916-017-0840-6","volume":"15","author":"S Perakis","year":"2017","unstructured":"Perakis S, Speicher MR (2017) Emerging concepts in liquid biopsies. BMC Med 15(1):75. https:\/\/doi.org\/10.1186\/s12916-017-0840-6","journal-title":"BMC Med"},{"issue":"2","key":"5869_CR84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gpb.2016.12.004","volume":"15","author":"X Han","year":"2017","unstructured":"Han X, Wang J, Sun Y (2017) Circulating tumor DNA as biomarkers for cancer detection. Genom Proteom Bioinform 15(2):59\u201372. https:\/\/doi.org\/10.1016\/j.gpb.2016.12.004","journal-title":"Genom Proteom Bioinform"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05869-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05869-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T23:06:31Z","timestamp":1633561591000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05869-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":84,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["5869"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05869-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}